University of Texas Southwestern Simmons Cancer Center - Fort Worth — Fort Worth, Texas

University of Texas Southwestern Simmons Cancer Center - Fort Worth is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Texas Southwestern Simmons Cancer Center - Fort Worth has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas Southwestern Simmons Cancer Center - Fort Worth?

University of Texas Southwestern Simmons Cancer Center - Fort Worth has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas Southwestern Simmons Cancer Center - Fort Worth conducted?

University of Texas Southwestern Simmons Cancer Center - Fort Worth has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer.

Is University of Texas Southwestern Simmons Cancer Center - Fort Worth accredited by Crixeo Health?

University of Texas Southwestern Simmons Cancer Center - Fort Worth has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas Southwestern Simmons Cancer Center - Fort Worth?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.